The Global Lancets Market: Industry Overview and Competitive Landscape


The lancets industry is poised for significant growth and innovation in the near future. Lancets, which are small, pricking devices used for blood sampling, play a crucial role in various healthcare settings, including home-based testing, diagnostics, and monitoring of chronic conditions such as diabetes. In the coming years, we can expect several advancements in lancet technology and design to improve patient experience, safety, and accuracy.

Lancets Market in terms of revenue was estimated to be worth $2.3 billion in 2023 and is poised to reach $3.6 billion by 2028, growing at a CAGR of 9.7% from 2023 to 2028 according to a new report by MarketsandMarkets™. Growth in the lancets market is mainly driven by the growing prevalence of diabetes, the high prevalence of chronic diseases, the rising geriatric population, and the increasing demand for painless lancets.

Download PDF Brochure:

Browse in-depth TOC on “Lancets Industry

206 – Tables

44 – Figures

219 – Pages

Safety Lancets segment is expected to account for the largest share in 2022.

The lancets market, by type has been segmented into safety and standard lancets. Increasing demand for painless lancets is expected to drive the safety lancets market. The increasing demand for painless lancets can be attributed to improved patient comfort, increased prevalence of diabetes, improved technology, and convenience. As healthcare technology continues to advance, there will be more innovations in painless lancet technology to meet the growing demand.

The Glucose Testing segment held the largest market share in the application market.

By application, the global lancets market is broadly segmented into Glucose Testing, Hemoglobin Testing, Coagulation Testing, Cholesterol Testing, Allergy Testing and Neonatal Screening. Growing prevalence of diabetes and increasing adoption of self-monitoring devices have revolutionized the application of lancets in research. According to the Centers for Disease Control and Prevention (CDC), in 2020, more than 34 million Americans had diabetes, which is nearly 11% of the US population. There are 1.5 million new cases of diabetes in the United States each year.

North America dominates the global lancets market

Based on the region, the lancets market is segmented into North America, Europe, Asia Pacific and Rest of the world. North America market is driven by growing focus on rising prevalence of various chronic diseases and growing geriatric population.   Thus, the rising geriatric population and the corresponding increase in the incidence of chronic diseases have increased the demand for lancets for early disease diagnostics. According to the WHO, globally, by 2030, 1 in every 6 individuals will be aged 60 years or over in the world. By 2050, the world’s geriatric population (aged 60 years and older) will witness a two-fold increase (2.1 billion). The number of individuals aged 80 years or older is expected to grow three times between 2020 and 2050 to reach 426 million. There are over 46 million older adults living in the US as of 2021, and by 2050, the geriatric population is expected to grow to over 90 million.

Request 10% Customization:

Key Market Players:

Major players in lancets market include Becton, Dickinson and Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), B. Braun SE (Germany), and Abbott Laboratories (US).

Recent Developments:

  • In 2023, Astellas Pharma announced that it has entered into an agreement with Roche Diabetes Care Japan Co., Ltd. for the development and commercialization of Roche Diabetes Care’s world-renowned Accu-Chek Guide Me blood glucose monitoring system with advanced accuracy as a combined medical product with BlueStar.
  • In 2022, BD announced the completion of the spinoff of Embecta Corp., which holds BD’s former Diabetes Care business and is one of the largest diabetes management companies in the world.
  • In 2021, Greiner Bio-One introduced MiniCollect PIXIE Heel Incision Safety Lancet to expand its portfolio. The new safety lancet is specially designed for heel incisions.

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.


Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441 Email: